These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21220930)

  • 1. Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes.
    Zhang Y; Zhang L; Chu W; Wang B; Zhang J; Zhao M; Li X; Li B; Lu Y; Yang B; Shan H
    Cell Physiol Biochem; 2010; 26(6):991-8. PubMed ID: 21220930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone IIA improves miR-133 expression through MAPK ERK1/2 pathway in hypoxic cardiac myocytes.
    Zhang L; Wu Y; Li Y; Xu C; Li X; Zhu D; Zhang Y; Xing S; Wang H; Zhang Z; Shan H
    Cell Physiol Biochem; 2012; 30(4):843-52. PubMed ID: 22890296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1.
    Shan H; Li X; Pan Z; Zhang L; Cai B; Zhang Y; Xu C; Chu W; Qiao G; Li B; Lu Y; Yang B
    Br J Pharmacol; 2009 Nov; 158(5):1227-35. PubMed ID: 19775284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA promotes pulmonary artery smooth muscle cell apoptosis in vitro by inhibiting the JAK2/STAT3 signaling pathway.
    Chen M; Liu Y; Yi D; Wei L; Li Y; Zhang L
    Cell Physiol Biochem; 2014; 33(4):1130-8. PubMed ID: 24733040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus kinase/signal transducer and activator of transcription inhibitors enhance the protective effect mediated by tanshinone IIA from hypoxic/ischemic injury in cardiac myocytes.
    Zhang MQ; Tu JF; Chen H; Shen Y; Pang LX; Yang XH; Sun RH; Zheng YL
    Mol Med Rep; 2015 Apr; 11(4):3115-21. PubMed ID: 25502794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P38 MAPK/miR-1 are involved in the protective effect of EGCG in high glucose-induced Cx43 downregulation in neonatal rat cardiomyocytes.
    Yu L; Yu H; Li X; Jin C; Zhao Y; Xu S; Sheng X
    Cell Biol Int; 2016 Aug; 40(8):934-42. PubMed ID: 27306406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway.
    Hong HJ; Liu JC; Chen PY; Chen JJ; Chan P; Cheng TH
    Int J Cardiol; 2012 May; 157(2):174-9. PubMed ID: 21190747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanshinone IIA prevented brain iron dyshomeostasis in cerebral ischemic rats.
    Yang L; Zhang B; Yin L; Cai B; Shan H; Zhang L; Lu Y; Bi Z
    Cell Physiol Biochem; 2011; 27(1):23-30. PubMed ID: 21325818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs/mTOR-dependent autophagy pathway.
    Zhang X; Wang Q; Wang X; Chen X; Shao M; Zhang Q; Guo D; Wu Y; Li C; Wang W; Wang Y
    Biomed Pharmacother; 2019 Apr; 112():108599. PubMed ID: 30798134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA ameliorates apoptosis of cardiomyocytes induced by endoplasmic reticulum stress.
    Feng J; Li S; Chen H
    Exp Biol Med (Maywood); 2016 Dec; 241(18):2042-2048. PubMed ID: 27465140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK.
    Kuang D; Zhao X; Xiao G; Ni J; Feng Y; Wu R; Wang G
    Basic Res Cardiol; 2008 May; 103(3):265-73. PubMed ID: 18087667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calreticulin expression increases during delayed cardioprotection induced by hypoxic preconditioning].
    Xu FF; Fu Y; Liu FY; Zhu XM; Liu XH
    Sheng Li Xue Bao; 2006 Dec; 58(6):536-46. PubMed ID: 17173188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury.
    Wang D; Liu Y; Zhong G; Wang Y; Zhang T; Zhao Z; Yan X; Liu Q
    J Ethnopharmacol; 2017 May; 204():67-76. PubMed ID: 28389356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone IIA Prevents Leu27IGF-II-Induced Cardiomyocyte Hypertrophy Mediated by Estrogen Receptor and Subsequent Akt Activation.
    Weng YS; Wang HF; Pai PY; Jong GP; Lai CH; Chung LC; Hsieh DJ; HsuanDay C; Kuo WW; Huang CY
    Am J Chin Med; 2015; 43(8):1567-91. PubMed ID: 26621443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia.
    Yin H; Zhang J; Lin H; Wang R; Qiao Y; Wang B; Liu F
    Inflammation; 2008 Apr; 31(2):65-73. PubMed ID: 17943427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycemia suppresses cardiac stem cell homing to peri-infarcted myocardium via regulation of ERK1/2 and p38 MAPK activities.
    She T; Wang X; Gan Y; Kuang D; Yue J; Ni J; Zhao X; Wang G
    Int J Mol Med; 2012 Dec; 30(6):1313-20. PubMed ID: 22965067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway.
    Mao S; Wang L; Chen P; Lan Y; Guo R; Zhang M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S707-S716. PubMed ID: 30284484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation.
    Yang R; Liu A; Ma X; Li L; Su D; Liu J
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):396-401. PubMed ID: 18427283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF-mediates Down-regulation of MicroRNA-195 Inhibits Ischemic Cardiac Apoptosis in Rats.
    Hang P; Sun C; Guo J; Zhao J; Du Z
    Int J Biol Sci; 2016; 12(8):979-89. PubMed ID: 27489501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The caspase-1 inhibitor VX765 upregulates connexin 43 expression and improves cell-cell communication after myocardial infarction via suppressing the IL-1β/p38 MAPK pathway.
    Su XL; Wang SH; Komal S; Cui LG; Ni RC; Zhang LR; Han SN
    Acta Pharmacol Sin; 2022 Sep; 43(9):2289-2301. PubMed ID: 35132192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.